| |
β
|
p
|
OR (95% CI)
|
|---|
|
Dose of corticosteroidsa (mg) when relapsed or at the end of follow-up
|
0.280
|
0.001
|
1.323 (1.129, 1.550)
|
|
Taking antimalarials when relapsed or at the end of follow-up
|
− 3.105
|
0.010
|
0.045 (0.004, 0.474)
|
|
Taking immunosuppressants when relapsed or at the end of follow-up
|
− 1.102
|
0.004
|
0.332 (0.156, 0.706)
|
- Variables included in the model: dose of corticosteroids (mg) when relapsed or at the end of follow-up, taking antimalarials when relapsed or at the end of follow-up, taking immunosuppressants when relapsed or at the end of follow-up, duration of serological activity before SACQ (months), anti-dsDNA (+), and/or hypocomplementemia
- aCorticosteroid doses were converted to milligrams (mg) of prednisone equivalent
